ClinicalTrials.gov
ClinicalTrials.gov Menu

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00995540
Recruitment Status : Terminated (Preserve clinical supplies)
First Posted : October 15, 2009
Last Update Posted : February 12, 2014
Sponsor:
Information provided by (Responsible Party):
Exsulin Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2011
  Actual Study Completion Date : December 2011